304 related articles for article (PubMed ID: 23118011)
1. Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors.
Sur IK; Hallikas O; Vähärautio A; Yan J; Turunen M; Enge M; Taipale M; Karhu A; Aaltonen LA; Taipale J
Science; 2012 Dec; 338(6112):1360-3. PubMed ID: 23118011
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Yekkala K; Baudino TA
Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
[TBL] [Abstract][Full Text] [Related]
3. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.
Wasserman NF; Aneas I; Nobrega MA
Genome Res; 2010 Sep; 20(9):1191-7. PubMed ID: 20627891
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells.
Wright JB; Brown SJ; Cole MD
Mol Cell Biol; 2010 Mar; 30(6):1411-20. PubMed ID: 20065031
[TBL] [Abstract][Full Text] [Related]
5. Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse.
Ignatenko NA; Holubec H; Besselsen DG; Blohm-Mangone KA; Padilla-Torres JL; Nagle RB; de Alboránç IM; Guillen-R JM; Gerner EW
Cancer Biol Ther; 2006 Dec; 5(12):1658-64. PubMed ID: 17106247
[TBL] [Abstract][Full Text] [Related]
6. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
Roland J; Morello D
Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795
[TBL] [Abstract][Full Text] [Related]
7. The intestinal nuclear receptor signature with epithelial localization patterns and expression modulation in tumors.
Modica S; Gofflot F; Murzilli S; D'Orazio A; Salvatore L; Pellegrini F; Nicolucci A; Tognoni G; Copetti M; Valanzano R; Veschi S; Mariani-Costantini R; Palasciano G; Schoonjans K; Auwerx J; Moschetta A
Gastroenterology; 2010 Feb; 138(2):636-48, 648.e1-12. PubMed ID: 19818784
[TBL] [Abstract][Full Text] [Related]
8. Cancer. The utility of mouse models in post-GWAS research.
Lewis A; Tomlinson I
Science; 2012 Dec; 338(6112):1301-2. PubMed ID: 23224545
[No Abstract] [Full Text] [Related]
9. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V
Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471
[TBL] [Abstract][Full Text] [Related]
10. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive strategy to combat colon cancer targeting the adenomatous polyposis coli tumor suppressor gene.
Gerner EW; Ignatenko NA; Lance P; Hurley LH
Ann N Y Acad Sci; 2005 Nov; 1059():97-105. PubMed ID: 16382048
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
13. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J
Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of in vivo gene delivery by restriction enzyme PCR generated polymorphism.
Fichera A; Guo Y; Romero L; Michelassi F; Arenas RB
J Surg Res; 1997 Apr; 69(1):188-92. PubMed ID: 9202668
[TBL] [Abstract][Full Text] [Related]
15. Mice deficient of
Dave K; Sur I; Yan J; Zhang J; Kaasinen E; Zhong F; Blaas L; Li X; Kharazi S; Gustafsson C; De Paepe A; Månsson R; Taipale J
Elife; 2017 Jun; 6():. PubMed ID: 28583252
[TBL] [Abstract][Full Text] [Related]
16. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
17. No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue.
Prokunina-Olsson L; Hall JL
Mol Cancer; 2009 Nov; 8():96. PubMed ID: 19895682
[TBL] [Abstract][Full Text] [Related]
18. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
Pomerantz MM; Ahmadiyeh N; Jia L; Herman P; Verzi MP; Doddapaneni H; Beckwith CA; Chan JA; Hills A; Davis M; Yao K; Kehoe SM; Lenz HJ; Haiman CA; Yan C; Henderson BE; Frenkel B; Barretina J; Bass A; Tabernero J; Baselga J; Regan MM; Manak JR; Shivdasani R; Coetzee GA; Freedman ML
Nat Genet; 2009 Aug; 41(8):882-4. PubMed ID: 19561607
[TBL] [Abstract][Full Text] [Related]
19. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.
Tuupanen S; Turunen M; Lehtonen R; Hallikas O; Vanharanta S; Kivioja T; Björklund M; Wei G; Yan J; Niittymäki I; Mecklin JP; Järvinen H; Ristimäki A; Di-Bernardo M; East P; Carvajal-Carmona L; Houlston RS; Tomlinson I; Palin K; Ukkonen E; Karhu A; Taipale J; Aaltonen LA
Nat Genet; 2009 Aug; 41(8):885-90. PubMed ID: 19561604
[TBL] [Abstract][Full Text] [Related]
20. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
